Literature DB >> 21863057

Clinical utility gene card for: multiple endocrine neoplasia type 2.

Friedhelm Raue1, Susanne Rondot, Egbert Schulze, Sylwia Szpak-Ulczok, Barbara Jarzab, Karin Frank-Raue.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21863057      PMCID： PMC3234510          DOI： 10.1038/ejhg.2011.142

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  16 in total

1.  Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10.

Authors:  Karin Frank-Raue; Lisa A Rybicki; Zoran Erlic; Heiko Schweizer; Aurelia Winter; Ioana Milos; Sergio P A Toledo; Rodrigo A Toledo; Marcos R Tavares; Maria Alevizaki; Caterina Mian; Heide Siggelkow; Michael Hüfner; Nelson Wohllk; Giuseppe Opocher; Sárka Dvořáková; Bela Bendlova; Małgorzata Czetwertynska; Elżbieta Skasko; Marta Barontini; Gabriela Sanso; Christian Vorländer; Ana Luiza Maia; Attila Patocs; Thera P Links; Jan Willem de Groot; Michiel N Kerstens; Gerlof D Valk; Konstanze Miehle; Thomas J Musholt; Josefina Biarnes; Svetozar Damjanovic; Mihaela Muresan; Christian Wüster; Martin Fassnacht; Mariola Peczkowska; Christine Fauth; Henriette Golcher; Martin A Walter; Josef Pichl; Friedhelm Raue; Charis Eng; Hartmut P H Neumann
Journal:  Hum Mutat       Date:  2011-01       Impact factor: 4.878

2.  Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients.

Authors:  M Wiench; Z Wygoda; E Gubala; J Wloch; K Lisowska; J Krassowski; D Scieglinska; A Fiszer-Kierzkowska; D Lange; D Kula; M Zeman; J Roskosz; A Kukulska; Z Krawczyk; B Jarzab
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

Review 3.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

Review 4.  Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis.

Authors:  J R Hansford; L M Mulligan
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

5.  Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes.

Authors:  Cristina Romei; Stefano Mariotti; Laura Fugazzola; Augusto Taccaliti; Furio Pacini; Giuseppe Opocher; Caterina Mian; Maurizio Castellano; Ettore degli Uberti; Isabella Ceccherini; Nadia Cremonini; Ettore Seregni; Fabio Orlandi; Piero Ferolla; Efisio Puxeddu; Francesco Giorgino; Annamaria Colao; Paola Loli; Fabio Bondi; Barbara Cosci; Valeria Bottici; Antonello Cappai; Giovanni Pinna; Luca Persani; Uberta Verga; Verga Uberta; Marco Boscaro; Maria Grazia Castagna; Carlo Cappelli; Maria Chiara Zatelli; Antongiulio Faggiano; Giuseppe Francia; Maria Luisa Brandi; Alberto Falchetti; Aldo Pinchera; Rossella Elisei
Journal:  Eur J Endocrinol       Date:  2010-06-01       Impact factor: 6.664

Review 6.  Update multiple endocrine neoplasia type 2.

Authors:  Friedhelm Raue; Karin Frank-Raue
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

Review 7.  Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC.

Authors:  Karin Frank-Raue; Susanne Rondot; Friedhelm Raue
Journal:  Mol Cell Endocrinol       Date:  2010-01-18       Impact factor: 4.102

8.  Early malignant progression of hereditary medullary thyroid cancer.

Authors:  Andreas Machens; Patricia Niccoli-Sire; Josef Hoegel; Karin Frank-Raue; Theo J van Vroonhoven; Hans-Dietrich Roeher; Robert A Wahl; Peter Lamesch; Friedhelm Raue; Bernard Conte-Devolx; Henning Dralle
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

9.  Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.

Authors:  Tracy S Wang; Idris Tolgay Ocal; Julie Ann Sosa; Heather Cox; Sanziana Roman
Journal:  Thyroid       Date:  2008-08       Impact factor: 6.568

Review 10.  Medullary thyroid cancer: management guidelines of the American Thyroid Association.

Authors:  Richard T Kloos; Charis Eng; Douglas B Evans; Gary L Francis; Robert F Gagel; Hossein Gharib; Jeffrey F Moley; Furio Pacini; Matthew D Ringel; Martin Schlumberger; Samuel A Wells
Journal:  Thyroid       Date:  2009-06       Impact factor: 6.568
View more
  1 in total

1.  Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.

Authors:  Malgorzata Oczko-Wojciechowska; Michal Swierniak; Jolanta Krajewska; Malgorzata Kowalska; Monika Kowal; Tomasz Stokowy; Bartosz Wojtas; Dagmara Rusinek; Agnieszka Pawlaczek; Agnieszka Czarniecka; Sylwia Szpak-Ulczok; Tomasz Gawlik; Ewa Chmielik; Tomasz Tyszkiewicz; Barbara Nikiel; Dariusz Lange; Michal Jarzab; Malgorzata Wiench; Barbara Jarzab
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.